LINC 2014 Programme

Find all topics and speakers listed below.

Main Arena 1

24 events
  • Tuesday, January 28th: - , Main Arena 1

    Symposium: Challenges of the SFA – stent properties and design and deployment techniques affecting outcomes

    Chairman:
    Johannes Lammer, Dierk Scheinert
    Moderator:
    Stefan Müller-Hülsbeck, Martin Funovics, Richard Rapoza
    1. -

      Introduction by the chairman

    2. -

      Stent design, radial outforce and oversizing – do they affect outcomes? Research data

        Martin Funovics
    3. -

      How to optimize outcomes in the SFA?

        Stefan Müller-Hülsbeck
    4. -

      Live case transmission from Leipzig

    5. -

      BVS – the future of PAD treatment

        Richard Rapoza
    6. -

      BVS in the SFA – 1 year Esprit results

        Johannes Lammer
    7. -

      Live case transmission from Aalst

    8. -

      Discussion and conclusion

  • Tuesday, January 28th: - , Main Arena 1

    A decade of innovation: Advances and future perspectives in cardiovascular medicine

    Chairman:
    Dierk Scheinert, Giancarlo Biamino
    Moderator:
    Frank Criado, Giovanni Torsello, Christoph Nienaber, William Gray, Krishna Rocha-Singh
    1. -

      The evolution of endovascular aortic repair – How far have we come?

        Frank Criado
    2. -

      Low profile solution for abdominal aortic aneurysms

    3. -

      INCRAFT AAA stent graft: 2 year results from the INNOVATION trial

        Giovanni Torsello
    4. -

      The European Ovation 500 patients registry

        Dierk Scheinert
    5. -

      Live case transmission from Leipzig

    6. -

      Should endovascular repair finally be considered the primary treatment for Type B aortic dissections?

        Christoph Nienaber
    7. -

      Pioneering techniques in cardiovascular medicine

    8. -

      Advanced interventional treatment concepts for structural heart disease: Update on TAVI and beyond

        Gerhard Schuler
    9. -

      TAVI with cerebral protection – video case

        Stephan Haußig
    10. -

      REDUCE-HTN trial: Renal denervation with a percutaneous bipolar RF balloon catheter in patients with resistant hypertension

        Dierk Scheinert
    11. -

      Live case transmission from Berlin

    12. -

      Renal denervation therapy – what we know and what we don't know

        Krishna Rocha-Singh
  • Tuesday, January 28th: - , Main Arena 1

    Symposium: Global perspective - when to use drug-eluting devices for the SFA

    Chairman:
    Michael Dake
    Moderator:
    Marc Bosiers
    1. -

      Introduction and Zilver PTX – 4 year results

        Michael Dake
    2. -

      Live case transmission from Leipzig

    3. -

      US Zilver PTX experience

    4. -

      Live case transmission from Aalst

    5. -

      Leave nothing behind – reality YES

        Dierk Scheinert
    6. -

      Leave nothing behind – reality NOT

        Marc Bosiers
    7. -

      How I use Zilver PTX in my practice

        Sebastian Sixt
    8. -

      Discussion and conclusion

  • Tuesday, January 28th: - , Main Arena 1

    Lunch

  • Tuesday, January 28th: - , Main Arena 1

    Symposium: Prime time for drug eluting balloons in femoro-poplitealinterventions? Hard facts and outstanding questions

    Chairman:
    Dierk Scheinert
    Moderator:
    Erich Minar, William Gray, Thomas Zeller, Sebastian Sixt, Marianne Brodmann
    1. -

      Introduction by the chairman

    2. -

      The IN.PACT SFA evidence overview and take-homes

        Dierk Scheinert
    3. -

      Live case transmission from Leipzig

    4. -

      The cost-effectiveness value of DEB in femoro-popliteal revascularization

        Thomas Zeller
    5. -

      From evidence to practice: how DEBs fit my daily work

        Marianne Brodmann
    6. -

      Live case transmission from Leipzig

    7. -

      Role and requisites of stents in the DEB era

        Sebastian Sixt
    8. -

      Discussion and conclusion

  • Tuesday, January 28th: - , Main Arena 1

    A decade of innovation: Current treatment, remaining challenges and future concepts for the femoropopliteal arteries

    Chairman:
    John Laird, Karl-Ludwig Schulte
    Moderator:
    Sumaira Macdonald, Chris Metzger, Hans Martin Gißler, Patrick Peeters
    1. -

      Stenting of the superficial femoral and popliteal artery: How good is the benchmark after years of optimisation?

        Erich Minar
    2. -

      2-year update on the SUPERB-study using a interwoven biomimetic nitinol stent in the SFA

        Kenneth Rosenfield
    3. -

      TASC D and beyond – 12 months results on the longest endoluminal bypass

        Thomas Zeller
    4. -

      Durability + Study: 12 months results

        Patrick Peeters
    5. -

      Latest clinical trials on drug-elution in femoropopliteal arteries

    6. -

      LEVANT II RCT

        Dierk Scheinert
    7. -

      PACIFIER RCT – 24 months update

        Michael Werk
    8. -

      My insights from DEB-RCTs: Breakthrough technology or just another tool in the box?

        Johannes Lammer
    9. -

      Live case transmission from Leipzig

    10. -

      Drug-elution with or without scaffolds for long lesions

        Thomas Zeller
    11. -

      Real world use of DEB in long femoropopliteal lesions – 2 year results

        Andrej Schmidt
    12. -

      Assessment of calcium burden and calcium effect on drug elution

        Fabrizio Fanelli
    13. -

      Less is more? Are more focal scaffolds the better solution?

        Renu Virmani
    14. -

      The concept of focal stenting – Lessons learned and future perspectives

        Klaus Amendt
    15. -

      TOBA study – initial results of the TACK system

        Thomas Zeller
    16. -

      Bioresorbable drug-eluting scaffolds for the SFA – new developments: The Elixir Medical program

        Dierk Scheinert
  • Tuesday, January 28th: - , Main Arena 1

    Symposium: Anti-restenosis treatment for SFA: Defining the new standard of care

    Chairman:
    Yann Gouëffic
    Moderator:
    Patrick Peeters, Stephan Duda, Arne Schwindt, Thomas Zeller
    1. -

      Introduction by the chairman

    2. -

      Evidence to support a standard of care: ILLUMENATE study series

        Patrick Peeters
    3. -

      ILLUMENATE First in human 12-month outcomes

        Stephan Duda
    4. -

      Live case transmission from Leipzig

    5. -

      Approaching the complex SFA lesion with stents

        Arne Schwindt
    6. -

      Live case transmission from Palermo

    7. -

      Beating the plaque burden with directional arterectomy: DEFINITIVE AR acute outcomes

        Thomas Zeller
    8. -

      Discussion and conclusion

  • Wednesday, January 29th: - , Main Arena 1

    Symposium: Renal denervation – insights and applications

    Chairman:
    Dierk Scheinert
    Moderator:
    Christoph Nienaber, Piero Montorsi, Stefan Müller-Hülsbeck
    1. -

      Introduction by the chairman

    2. -

      Procedural and anatomic considerations

        Dierk Scheinert
    3. -

      Live case transmission from Leipzig

    4. -

      Co-morbid states impacted by renal denervation – a review

        Stefan Müller-Hülsbeck
    5. -

      VESSIX renal denervation system, clinical update and future direction

    6. -

      Pre-recorded case

        Piero Montorsi
    7. -

      Referral pathways – patient centered teamwork

        Christoph Nienaber
    8. -

      Discussion and conclusion

  • Wednesday, January 29th: - , Main Arena 1

    A decade of innovation: Pioneering approaches and remaining challenges for limb salvage in CLI

    Chairman:
    Dierk Scheinert
    Moderator:
    Krishna Rocha-Singh, Thomas Zeller, Iris Baumgartner, Marc Bosiers, Frank Vermassen
    1. -

      Angiosome based treatment strategies in full BTK 3-vessel occlusion

        Vlad Alexandrescu
    2. -

      Live case transmission from Leipzig

    3. -

      Below-the-ankle arterial disease: when to treat and how

        Roberto Ferraresi
    4. -

      Latest clinical trials on drug-eluting for CLI

    5. -

      The rationale for drug-elution in BTK treatment – what is the requirement for vessel patency?

        Frank Vermassen
    6. -

      DEB vs. DES in CLI: Results from the IDEAS I RCT

        Panagiotis Kitrou
    7. -

      PES BTK 70 study: 6 months results with a self-expanding paclitaxel eluting stent in BTK

        Marc Bosiers
    8. -

      Clinical outcome after BTK DEB treatment in CLI - the Leipzig single centre experince - A. Schmidt

        Andrej Schmidt
    9. -

      Biolux PII - a randomized clinical trial of DEB vs. PTA for infrapopliteal disease: 6 months angiographic follow-up

        Marianne Brodmann
    10. -

      IN.PACT DEB in CLI and diabetes: 2 year results with the DEBATE BTK randomized clinical trial

        Francesco Liistro
    11. -

      DEB vs. PTA for infrapopliteal revascularisation: 12 months results from the IN.PACT DEEP randomized trial

        Thomas Zeller
    12. -

      A review of clinical evidence on CLI

        Krishna Rocha-Singh
    13. -

      Discussion and conclusion

  • Wednesday, January 29th: - , Main Arena 1

    Symposium: Unique technologies for the treatment of peripheral artery disease

    Chairman:
    Johannes Lammer
    Moderator:
    Peter Soukas, Dennis Gable, Michael Piorkowski, Po-Jen Ko
    1. -

      Introduction by the chairman

    2. -

      Demonstrated clinical success and technical considerations for covered stents in the SFA: Key learning from the VIPER and VIASTAR studies

        Dennis Gable
    3. -

      Live case transmission from Leipzig

    4. -

      Viabahn for in-stent restenosis treatment

        Po-Jen Ko
    5. -

      Live case transmission from Leipzig

    6. -

      12 months single center patency data for dual component bare metal stent in the SFA

        Michael Piorkowski
    7. -

      Discussion and conclusion

  • Wednesday, January 29th: - , Main Arena 1

    Lunch symposium: How do you treat your challenging aortoiliac stenotic lesion?

    Chairman:
    Dierk Scheinert
    Moderator:
    Gustavo Oderich, Piotr Kasprzak, Peter Goverde
    1. -

      Introduction by the chairman

    2. -

      Expanding the role of covered stents in aortoiliac lesions

        Gustavo Oderich
    3. -

      Aortoiliac disease; one year multi-center clinical update

        Piotr Kasprzak
    4. -

      Live case transmission from Leipzig

    5. -

      CERAB: flow-dynamic study and one year results

        Peter Goverde
  • Wednesday, January 29th: - , Main Arena 1

    Symposium: Lutonix drug coated balloons – clinical evidence and real world applications

    Chairman:
    Marianne Brodmann
    Moderator:
    Dierk Scheinert, Michael Lichtenberg, Francesco Liistro
    1. -

      Introduction by the chairman

    2. -

      LEVANT II study design and subgroup analysis

        Dierk Scheinert
    3. -

      Single center experience global SFA registry

        Michael Lichtenberg
    4. -

      Live case transmission from Berlin

    5. -

      BTK applications and Lutonix BTK clinical trial

        Marianne Brodmann
    6. -

      The benefit of drug coated balloons in complex BTK cases

        Francesco Liistro
    7. -

      Pre-clinical safety data and technology review

        Renu Virmani
    8. -

      A Single Center Experience with Lutonix

        Peter von Bilderling
    9. -

      Discussion and conclusion

  • Wednesday, January 29th: - , Main Arena 1

    VIVA @ LINC - Carotid bifurcation disease: pressing new dilemmas and pushing the field forward

    Chairman:
    Peter Schneider
    Moderator:
    Mehdi Shishehbor, John Laird, Tony Das, Marco Roffi, Carlo Setacci
    1. -

      Presentation of the Vascular Career Advancement Award, soponsored by VIVA and LINC. 2013/2014 Awardees: M. Shishehbor, Cleveland, USA and M. Werner, Vienna, Austria.

    2. -

      The case of repair of critical, but asymptomatic carotid stenosis

    3. -

      Live case transmission from Columbus

    4. -

      Future carotid trials and endpoints. This is how we make progress

        Tony Das
    5. -

      CAS is the right choice for patients who also require coronary bypass

        Mehdi Shishehbor
    6. -

      Live case transmission from Columbus

    7. -

      Advances in stents, protection devices, and patient selection will make CAS safer

        John Laird
    8. -

      Discussion and conclusion

  • Wednesday, January 29th: - , Main Arena 1

    Interventional techniques for visceral and renal arteries

    Chairman:
    Johannes Lammer, Barry Katzen
    Moderator:
    Felix Mahler, Steve Ramee, Ramon Varcoe, Sebastian Debus, Thomas Rand
    1. -

      Comparison of covered stents and bare metal stents for treatment of chronic mesenteric ischemia

        Gustavo Oderich
    2. -

      Is chronic visceral ischemia an underdiagnosed phenomenon? Interventional techniques and outcome

        Craig Walker
    3. -

      Live case transmission from Palermo

    4. -

      Management of renal and visceral artery aneurysms

        Barry Katzen
    5. -

      Live case transmission from Leipzig

    6. -

      The case for renal artery revascularization: My take away from all the clinical trials including CORAL

        Steve Ramee
    7. -

      Discussion

  • Thursday, January 30th: - , Main Arena 1

    Symposium: Vascular mimetic technology – Design, engineering, and clinical outcomes

    Chairman:
    Dierk Scheinert, Peter Goverde
    Moderator:
    Chris Metzger, Kenneth Rosenfield, Jan Peter Goltz
    1. -

      Introduction by the chairman

    2. -

      Vascular mimetic technology

        Peter Goverde
    3. -

      Live case transmission from Bad Krozingen

    4. -

      Clinical results from the SUPERB and Supera 500

        Dierk Scheinert
    5. -

      Real world data with Supera in the superficial femoral artery and popliteal artery – Results and clinical experience from the AURORAA trial

        Peter Goverde
    6. -

      Real world data with Supera in the superficial femoral artery and popliteal artery – Treatment of popliteal artery lesions in patients with CLI

        Jan Peter Goltz
    7. -

      Live case transmission from Leipzig

  • Thursday, January 30th: - , Main Arena 1

    A decade of innovation: Remaining challenges and future prospectives for the femoropopliteal arteries

    Chairman:
    Kenneth Rosenfield
    Moderator:
    Ralf Langhoff, Marc Bosiers, Craig Walker, Peter Soukas, Dai-Do Do
    1. -

      The Zilver PTX registry ISR subanalysis

        Michael Dake
    2. -

      2-year results of DEB for treatment of ISR

        Eugenio Stabile
    3. -

      The Debate-ISR study: 2-year data

        Francesco Liistro
    4. -

      Live case transmission from Leipzig

    5. -

      Latest clinical trials on treatment of in-stent restenosis

    6. -

      RELINE - randomized clinical trial: Viabahn covered stents vs. PTA

        Koen Deloose
    7. -

      The FAIR - randomized clinical trial of DEB vs. PTA for SFA-ISR

        Hans Krankenberg
    8. -

      Live case transmission from Bad Krozingen

    9. -

      Initial experience with DEB in occluded lower limb bypass

        Konstantinos Katsanos
    10. -

      BioMimics 3D - advanced stent design: Concept to randomised controlled trial

        Thomas Zeller, Via satellite from Bad Krozingen
    11. -

      Discussion and conclusion

  • Thursday, January 30th: - , Main Arena 1

    Symposium: Treatment of arterial and venous occlusions – "Why do I use mechanical debulking?"

    Chairman:
    Miroslav Bulvas
    Moderator:
    Eberhard Wedell, Steven Kum, Sven Bräunlich, Torsten Fuß, Thomas Heller
    1. -

      Introduction by the chairman

    2. -

      Rotarex in daily practice – indications and results of the last 10 years

        Sven Bräunlich
    3. -

      Live case transmission from Leipzig

    4. -

      Treatment of long segment ISR. Rotarex plus DEB improves the outcome

        Torsten Fuß
    5. -

      Recanalisation of venous thrombosis. Is there an advantage in using a mechanical thrombectomy system?

        Thomas Heller
    6. -

      Live case transmission from Bad Krozingen

    7. -

      Discussion and conclusion

  • Thursday, January 30th: - , Main Arena 1

    Lunch

  • Thursday, January 30th: - , Main Arena 1

    TCT @ LINC: Pioneering techniques and future perspectives in endovascular interventions. „Leaving no metal behind“ – the concept for the future?

    Chairman:
    William Gray
    Moderator:
    Gunnar Tepe, Renu Virmani, Sumaira Macdonald, Hans Martin Gißler, Tony Das, Johannes Lammer
    1. -

      Current evidence and clinical utility of atherectomy systems

        William Gray
    2. -

      The Phoenix Atherectomy System: My initial experience with the next generation of peripheral atherectomy

        Thomas Zeller, Via satellite from Bad Krozingen
    3. -

      Directional atherectomy + DEB: Early insights from the Definitive AR study

        Gunnar Tepe
    4. -

      The SHOCKWAVE lithoplasty concept for calcified lesions – initial clinical experience

        Marianne Brodmann
    5. -

      Live case transmission from Bad Krozingen

    6. -

      The only solution for peripheral arteries is to avoid permanent implants – bioabsorbable scaffolds will be the future!

        Renu Virmani
    7. -

      Latest generation bioabsorbable technology – how to make it work

        Dierk Scheinert
    8. -

      Live case transmission from Leipzig

    9. -

      Chocolate BAR: Chocolate PTA in a broad range of patients with peripheral arterial disease, a prospective post-marketing study

        Tony Das
  • Thursday, January 30th: - , Main Arena 1

    Scrub in with the experts: Advanced techniques for carotid revascularisation

    live from Münster:
    Arne Schwindt
    live from Palermo:
    Fausto Castriota
    Chairman:
    Giovanni Torsello
    Moderator:
    Sumaira Macdonald, Max Amor, Dariusz Dudek, Paolo Rubino
    1. -

      Flash presentation: Critical literature appraisal on carotid artery stenting

        Sumaira Macdonald
    2. -

      Flash presentation: Patient selection, techniques, and armamentarium: Lessons learned after CREST

        William Gray
    3. -

      Flash presentation: Pre-clinical and first clinical experiences with Micromesh carotid stent

        Max Amor
    4. -

      Flash presentation: Proximal protection during CAS

        Piotr Odrowaz-Pieniazek
  • Thursday, January 30th: - , Main Arena 1

    The last frontier: Endovascular interventions in the common femoral and popliteal arteries

    Chairman:
    Barry Katzen
    Moderator:
    Reza Ghotbi, Patrick Peeters, Chris Metzger, Ralph-Ingo Rückert, Peter Schneider
    1. -

      The TECCO trial: results of the French multicentric randomized clinical trial comparing endovascular vs. open surgery for the treatment of common femoral artery de novo lesions

        Yann Gouëffic
    2. -

      Live case transmission from Bad Krozingen

    3. -

      Anatomical and biomechanical specifics of the popliteal artery

        Stefan Müller-Hülsbeck
    4. -

      Clinical trial update: ETAP randomized clinical trial: 24 months update

        Thomas Zeller, Via satellite from Bad Krozingen
    5. -

      Clinical trial update: The Durability Pop study – 2 year results

        Patrick Peeters
    6. -

      The Leipzig SUPERA Popliteal artery stent registry - long-term results

        Johannes Schuster
    7. -

      Entrapment syndrome of the popliteal artery – diagnostic work-up and treatment

        Ralph-Ingo Rückert
    8. -

      Live case transmission from Leipzig

    9. -

      Endovascular repair of popliteal artery aneurysms: Technical considerations, patient selection, and outcome

        Barry Katzen
  • Friday, January 31st: - , Main Arena 1

    Join us for brunch!

  • Friday, January 31st: - , Main Arena 1

    Critical issues in aortic endografting

    Chairman:
    Michel Makaroun, Roberto Chiesa
    Moderator:
    Marc van Sambeek, Steven Kum, Eric Verhoeven, Giovanni Torsello, Armando Lobato
    1. -

      Live case transmission from Münster

    2. -

      EVAR improves outcomes of elective and ruptured AAA

        Marc Schermerhorn
    3. -

      Scientific and clinical value of contemporary EVAR post market registries: The ENGAGE case example

        Hence Verhagen
    4. -

      Long-term results with the Endurant stentgraft: The Muenster single center experience with 700+ patients

        Theodosios Bisdas
    5. -

      The real life GORE® GREAT registry: Latest clinical evidence and ongoing modules

        Patrick Vriens
    6. -

      TREOVANCE in EVAR: Latest results on ADVANCE, BENEFIT and RATIONALE clinical studies

        Vicente Riambau
    7. -

      Multicenter registry to evaluate the performance of chimney and periscope grafts

        Konstantinos Donas
    8. -

      Thinking out of the box: innovative solutions for challenging EVAR cases - Nellix and beyond

        Dittmar Böckler
    9. -

      Live case transmission from Leipzig

    10. -

      One year experience with complete endovascular repair of thoracoabdominal aneurysms by compartmentalizing aortic flow

        Patrick Kelly
    11. -

      Custom-made vs. off-the-shelf multibranched endografts for endovascular repair of TAAA

        Martin Austermann, Via satellite from Münster
    12. -

      My experience with parallel graft techniques as an off-the-shelf solution for complex aortic aneurysms

        Armando Lobato
    13. -

      Update on understanding and management of PAU and IMH

        Frank Criado
    14. -

      Retrograde Type A dissections after EVAR – insights from surgical re-do procedures

        Michael Borger
    15. -

      Live case transmission from Münster

    16. -

      Prevention and treatment of Type I endoleaks with the Aptus system

        Piotr Kasprzak
    17. -

      Late Type I endoleak are better treatable by chimneys

        Konstantinos Donas
    18. -

      Innovative system for iliac branch procedures: The new GORE® EXCLUDER® iliac branch endoprosthesis

        Fabio Verzini
    19. -

      9-year experience with the use of iliac side branch devices in more than 160 patients

        Giovanni Torsello
  • Friday, January 31st: - , Main Arena 1

    After completion of the programme, buses will leave from the congress venue directly to the airport, the trainstation, as well as back to the city center.

Cookie settings

We use cookies so that we can offer you the best possible website experience. This includes cookies which are necessary for the operation of the website and to manage our corporate commercial objectives, as well as other cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for the display of personalised content. With the exception of strictly necessary cookies, your are free to decide which categories you would like to permit. Please note that depending on the settings you choose, the full functionality of the website may no longer be available. Further information can be found in our privacy statement and cookie policy.

more info
  • Strictly necessary

    We are using cookies in order to enable the services of the website and to ensure that certain aspects work as required. The cookies within this group are essential for the correct appearance and functionality of the website. No information within these cookies will be given to third parties.

  • Analytical (Tracking) Cookies

    We're using functional tracking to analyze the usage of our website. The data hereby gathered, allows us to find errors and improve designs. It also enables us to test the efficacy of our website. These cookies furthermore help us in analyzing our advertisements and affiliate marketing.

  • Functionality Cookies

    Our website makes use of external services such as Issuu and Push-Panda. These services provide great value to us and to you as a user. However they do write cookies and collect data about their usage on this website. In order for you to be able to use these services, you will have to give your consent to their respective cookies.